Badoux, X. C., Keating, M. J., Wen, S., Wierda, W. G., O'Brien, S. M., Faderl, S., . . . Ferrajoli, A. (2013). Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia. J Clin Oncol.
Citação norma ChicagoBadoux, Xavier C., Michael J. Keating, Sijin Wen, William G. Wierda, Susan M. O'Brien, Stefan Faderl, Rachel Sargent, Jan A. Burger, and Alessandra Ferrajoli. "Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia." J Clin Oncol 2013.
Citação norma MLABadoux, Xavier C., et al. "Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia." J Clin Oncol 2013.